top of page

CONQUEST: The COllaboratioN on QUality improvement initiative for achieving Excellence in Standards of COPD care 

Asset 1_2x.png

Introducing CONQUEST

The COllaboratioN on QUality improvement initiative for achieving Excellence in STandards of COPD care (CONQUEST) is a novel, collaborative, interventional COPD registry. It comprises an integrated quality improvement programme focusing on patients (diagnosed and undiagnosed) at a modifiable and higher risk of COPD exacerbations. CONQUEST is underpinned by four evidence-based Quality Standards developed by 11 experts internationally recognised in their field. 

CONQUEST drives long-term, targeted, patient-centred changes in COPD management. The promotion of expert and guideline-led care aims to reduce exacerbation frequency and improve healthcare outcomes

Building the CONQUEST Registry

Medical records from >1,020,000 patients in the CONQUEST Registry

3 core locality areas involved 

►168 primary sites recruited

►100% baseline data provided

► 3 integrated health care systems

120 primary care teams recruited

100% baseline data provided

White Waves

Quality Improvement Programme

About the CONQUEST quality improvement programme

A programme supporting healthcare teams to identify opportunities for improved diagnosis, care and management of their COPD patients. The four quality standards have been translated into a programme of activities that embed quality improvement into routine care.

Revised Implementation Flow Graphic - CONQUEST Website .jpg
White Waves

Get involved in CONQUEST

Healthcare systems wishing to join the CONQUEST programme must meet the minimum requirements necessary for implementation.

Revised Minimum Requirements Infographic - CONQUEST Website.jpg

Available Resources

Specific resources will be available to registered healthcare systems or practices meeting the minimum requirements. These include:
 

  • A framework for implementation 

  • A clinical decision support package

  • The CONQUEST questionnaire

  • Quality indicators for programme evaluation

If you are interested in implementing CONQUEST in your healthcare system or you wish to find out more about the programme and the resources available, please contact the team at:
info.conquest@optimumpatientcare.org .

Publications and Media

 CONQUEST US Opportunity Analysis 

Margee Kerr, Yasir Tarabichi, Alexander Evans, Douglas Mapel, Wilson Pace, Victoria Carter, Amy Couper, M Bradley Drummond, Norbert Feigler, Alex Federman, Hitesh Gandhi, Nicola A Hanania, Alan Kaplan, Konstantinos Kostikas, Maja Kruszyk, Marije van Melle, Hana Müllerová, Ruth Murray, Jill Ohar, Michael Pollack, Rachel Pullen, Dennis Williams, Juan Wisnivesky, MeiLan K Han, Catherine Meldrum, David Price. Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program. Lancet Reg Health Am. 2023.

CONQUEST UK Opportunity Analysis 

David M. G. Halpin, Andrew P. Dickens, Derek Skinner, Ruth Murray, Mukesh Singh, Katherine Hickman, Victoria Carter, Amy Couper, Alexander Evans, Rachel Pullen, Shruti Menon, Tamsin Morris, Hana Muellerova, Mona Bafadhel, James Chalmers, Graham Devereux, Martin Gibson, John R. Hurst, Rupert Jones, Konstantinos Kostikas, Jennifer Quint, Dave Singh, Marije van Melle, Tom Wilkinson, David Price. Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study. Lancet Reg Health Eur. 2023.

CONQUEST QUALITY STANDARDS

Rachel Pullen, Marc Miravitlles, Anita Sharma, Dave Singh, Fernando Martinez, John R Hurst, Luis Alves, Mark Dransfield, Rongchang Chen, Shigeo Muro, Tonya Winders, Christopher Blango, Hana Muellerova, Frank Trudo, Paul Dorinsky, Marianna Alacqua, Tamsin Morris, Victoria Carter, Amy Couper, Rupert Jones, Konstantinos Kostikas, Ruth Murray, David B Price. CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. Int J Chron Obstruct Pulmon Dis 2021.

CONQUEST: A QUALITY IMPROVEMENT PROGRAM FOR DEFINING AND OPTIMIZING STANDARDS OF CARE FOR MODIFIABLE HIGH-RISK COPD PATIENTS

Luis Alves, Rachel Pullen, John R Hurst, Marc Miravitlles, Victoria Carter, Rongchang Chen, Amy Couper, Mark Dransfield, Alexander Evans, Antony Hardjojo, David Jones, Rupert Jones, Margee Kerr, Konstantinos Kostikas, Jonathan Marshall, Fernando Martinez, Marije van Melle, Ruth Murray, Shigeo Muro, Clementine Nordon, Michael Pollack, Chris Price, Anita Sharma, Dave Singh, Tonya Winders, David B Price. CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients. Patient Relat Outcome Meas 2022.

Combined CONQUEST Information Package

A package of published works, slide deck presentations and other summary materials

CONQUEST Collaborators: Committee Membership  

Committee Type
Committee Member
Committee Member Affiliation
Country Represented
Global  
Anita Sharma 
Platinum Medical Center, Queensland  
Australia 
Global  
Daiana Stolz 
University of Freiberg, Freiberg  
Germany 
Global  
Dave Singh 
The University of Manchester, Manchester  
United Kingdom   
Global  
David Price 
Observational and Pragmatic Research Institute, Singapore 
Singapore 
Global  
Fernando Martinez 
Weill Cornell Medicine, New York 
United States of America 
Global  
John Hurst 
University College London, London 
United Kingdom 
Global  
Luis Alves  
University of Porto, Porto 
Portugal   
Global  
Marc Miravitlles 
Vall d’Hebron University Hospital, Barcelona 
Spain 
Global  
Mohit Bhutani 
University Of Alberta, Alberta  
Canada 
Global  
Rongchang Chen 
Shenzhen Institute of Respiratory Diseases, and the Guangzhou Institute of Respiratory Health, Guangzhou  
China 
Global  
Shigeo Muro 
Nara Medical University, Nara 
Japan 
Global  
Tonya Winders 
The Global Allergy & Airways Patient Platform 
United States of America 
National (UK) 
Chris Gale 
University of Leeds, Leeds, England  
United Kingdom 
National (UK) 
David Halpin 
University of Exeter, Exeter, England  
United Kingdom 
National (UK) 
Graham Devereux 
Liverpool School of Tropical Medicine, Liverpool, England  
United Kingdom 
National (UK) 
James Chalmers 
University of Dundee, Dundee, Scotland  
United Kingdom 
National (UK) 
Jennifer Quint 
Imperial College London, London, England  
United Kingdom 
National (UK) 
Katherine Hickman 
Low Moor Medical Practice, Bradford, and National Health Service (NHS) West Yorkshire Integrated Care Board, England 
United Kingdom 
National (UK) 
Martin Gibson 
The University of Manchester, and North West E-Health, Manchester, England 
United Kingdom 
National (UK) 
Michael Crooks 
The University of Hull, and Hull University Teaching Hospitals NHS Trust, Hull, England 
United Kingdom 
National (UK) 
Mona Bafadhel 
King’s College London, London, England 
United Kingdom 
National (UK) 
Mukesh Singh 
Horse Fair Practice Group, Rugeley, and Keele University Medical School, Staffordshire, England 
United Kingdom 
National (UK) 
Tom Wilkinson 
University of Southampton, Southampton, England  
United Kingdom 
National (USA) 
Alan Kaplan 
The University of Toronto, Toronto, and the Family Physician Airways Group of Canada, Ontario 
Canada 
National (USA) 
Barry Make  
National Jewish Health, Denver, Colorado 
United States of America 
National (USA) 
M. Bradley Drummond  
University of North Carolina at Chapel Hill, North Carolina  
United States of America 
National (USA) 
Catherine Meldrum 
University of Michigan, Ann Arbor, Michigan  
United States of America 
National (USA) 
Douglas Mapel  
Northern Arizona Pulmonary Associates, Arizona  
United States of America 
National (USA) 
Jill Ohar  
Wake Forest University, Winston-Salem, North Carolina 
United States of America 
National (USA) 
MeiLan Han  
University of Michigan, Ann Arbor, Michigan  
United States of America 
National (USA) 
Nick Hanania 
Baylor College of Medicine, Houston, Texas 
United States of America 
National (USA) 
Tonya Winders  
The Global Allergy & Airways Patient Platform 
United States of America  
National (USA) 
Wilson Pace  
DARTNet Institute, Aurora, and the University of Colorado, Denver, Colorado  
United States of America 

NETWORK

CONQUEST Network and Database

OPCRD
OPC Global
OPC UK
OPRI
PREVAIL

A European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP®) Registered Datasource (ENCEPP/DSPP/42512)

White Waves

CONTACT

For further information on the CONQUEST quality improvement programme please contact the team at:

5 Coles Lane, Oakington, Cambridgeshire, CB24 3BA, UK

CONQUEST is co-funded by Optimum Patient Care Global Limited and AstraZeneca Ltd. AstraZeneca is the sole external funder of this work.

Optimum Patient Care’s Facilities and Administration Costs Policies (for US institutions/projects only) It is the policy of Optimum Patient Care Limited (OPC) to charge facilities and administration fees (F&A) for grants and contracts undertaken by OPC. In cases other than where a set federal F&A rate has been established, OPC will accept the specific F&A rate publicly established by a given not-for-profit funding agency for grant or contract activities as long as it meets or exceeds the currently established OPC minimum rate. The minimum acceptable F&A rate of OPC is 10% without special dispensation. The F&A rate for industry funded grants and contracts is 25% and it is OPC policy to not pay a higher rate than this. OPC will distribute F&A fees to sub-contractors prorated to the direct costs included in the sub-contract. OPC will pay sub-contractors the facilities and administration percentage of direct costs as established by the specific funding agency for a particular grant, or for federal grants at the established federal rate for the sub-contractor. OPC will also collect facility and administration fees on the first $25,000 of a sub-contract for the life of a grant or contract. The sub-contractor may also request facilities and administration fees for the initial $25,000 of a sub-contract. If duplicate facilities and administration fees are not allowed for sub-contracts by a funding agency then the fees associated with the first $25,000 of direct costs will be equally paid to the sub-contractor and OPC. OPC does not pay facilities and administration fees for purchased services or consultation services.

bottom of page